Food intolerance and diagnostics company Omega Diagnostics has delayed its interim results announcement, although it figures appear likely to be in line with expectations.
Omega wants to firm up commercial discussions and post-balance sheet events. There will still be a small loss in the year to March 2019.
The first VISITECT CD4 order has been received from Nigeria. This HIV diagnostic test is important for Omega’s future. The Nigerian distributor ordered 50,000 units valued at £210,000. The Nigerian Ministry of Health does have to approve the test for its HIV policy before the order goes ahead.
There is also a Chinese order for 20,000 Food Detective units worth £290,000.
Despite the positive news, the delay was not taken well by the share price which fell 0.75p to 8.75p.
© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Omega Diagnostics will lose money this year, but it is on course to become profitable in 2020-21 as sales of the VISITECT CD4 test.
House broker Shore Capital has slashed its pre-tax profit forecast for engineer Tricorn Group by two-thirds to £420,000.
Evgen Pharma has entered into an agreement with The University of Dundee for the use of SFX-01 in a clinical trial in non-alcoholic steatohepatitis and liver fibrosis, where there is no existing treatment.